BI-1291583

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for BI-1291583, covering 2025-08-13 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis [Phase 3]